{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T08:28:46Z","timestamp":1787819326730,"version":"build-2784847793"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,3]],"date-time":"2024-11-03T00:00:00Z","timestamp":1730592000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Taiwanese Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.tjog.2024.09.020","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T15:46:05Z","timestamp":1736351165000},"page":"76-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["FIGO 2023 staging system predicts not only survival outcome but also recurrence pattern in corpus-confined endometrial cancer patients"],"prefix":"10.1016","volume":"64","author":[{"given":"Hua-Hsi","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Tse","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Yao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiung-Ru","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Jen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.tjog.2024.09.020_bib1","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ygyno.2021.01.036","article-title":"Variations in incidence and mortality rates of endometrial cancer at the global, regional, and national levels, 1990-2019","volume":"161","author":"Gu","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.tjog.2024.09.020_bib2","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1001\/jamaoncol.2022.0009","article-title":"Racial and ethnic differences in hysterectomy-corrected uterine corpus cancer mortality by stage and histologic subtype","volume":"8","author":"Clarke","year":"2022","journal-title":"JAMA Oncol"},{"issue":"10333","key":"10.1016\/j.tjog.2024.09.020_bib3","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0140-6736(22)00323-3","article-title":"Endometrial cancer","volume":"399","author":"Crosbie","year":"2022","journal-title":"Lancet."},{"issue":"1","key":"10.1016\/j.tjog.2024.09.020_bib4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ygyno.2019.04.676","article-title":"Recurrent early stage endometrial cancer: patterns of recurrence and results of salvage therapy","volume":"154","author":"Francis","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.tjog.2024.09.020_bib5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejca.2016.09.033","article-title":"The nature of early-stage endometrial cancer recurrence-A national cohort study","volume":"69","author":"Jeppesen","year":"2016","journal-title":"Eur J Cancer"},{"issue":"11","key":"10.1016\/j.tjog.2024.09.020_bib6","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/bjc.2016.337","article-title":"Predicting poor prognosis recurrence in women with endometrial cancer: a nomogram developed by the FRANCOGYN study group","volume":"115","author":"Ouldamer","year":"2016","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.tjog.2024.09.020_bib7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijgo.2009.02.009","article-title":"Revised FIGO staging for carcinoma of the cervix","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"issue":"7471","key":"10.1016\/j.tjog.2024.09.020_bib8","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature12634","article-title":"Mutational landscape and significance across 12 major cancer types","volume":"502","author":"Kandoth","year":"2013","journal-title":"Nature"},{"issue":"29","key":"10.1016\/j.tjog.2024.09.020_bib9","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1200\/JCO.20.00549","article-title":"Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: impact on prognosis and benefit from adjuvant therapy","volume":"38","author":"Leon-Castillo","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.tjog.2024.09.020_bib10","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/annonc\/mdy058","article-title":"Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series","volume":"29","author":"Kommoss","year":"2018","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.tjog.2024.09.020_bib11","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/bjc.2015.190","article-title":"A\u00a0clinically applicable molecular-based classification for endometrial cancers","volume":"113","author":"Talhouk","year":"2015","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.tjog.2024.09.020_bib12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin","year":"2021","journal-title":"Int J Gynecol Cancer"},{"issue":"9","key":"10.1016\/j.tjog.2024.09.020_bib13","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.annonc.2022.05.009","article-title":"Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Oaknin","year":"2022","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.tjog.2024.09.020_bib14","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ijgo.14923","article-title":"FIGO staging of endometrial cancer: 2023","volume":"162","author":"Berek","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.tjog.2024.09.020_bib15","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ygyno.2024.01.040","article-title":"2023 changes to FIGO endometrial cancer staging: counterpoint","volume":"184","author":"Leitao","year":"2024","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.tjog.2024.09.020_bib16","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.ygyno.2020.12.021","article-title":"Endometrial cancer: a society of gynecologic oncology evidence-based review and recommendations","volume":"160","author":"Hamilton","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.tjog.2024.09.020_bib17","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1136\/ijgc-2023-004981","article-title":"FIGO 2023 endometrial cancer staging: too much, too soon?","volume":"34","author":"McCluggage","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.tjog.2024.09.020_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.113317","article-title":"Verification of the prognostic precision of the new 2023 FIGO staging system in endometrial cancer patients - an international pooled analysis of three ESGO accredited centres","volume":"193","author":"Schwameis","year":"2023","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.tjog.2024.09.020_bib19","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/PAS.0000000000002143","article-title":"The 2023 FIGO staging system for endometrial carcinoma: predicted impact on stage distribution based on a retrospective analysis of 1169 cases","volume":"48","author":"Schilling","year":"2024","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.tjog.2024.09.020_bib20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ygyno.2022.11.012","article-title":"Recurrence and survival in endometrioid endometrial cancer - a population-based cohort study","volume":"168","author":"Akesson","year":"2023","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.tjog.2024.09.020_bib21","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1470-2045(18)30079-2","article-title":"Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial","volume":"19","author":"de Boer","year":"2018","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.tjog.2024.09.020_bib22","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S1470-2045(19)30395-X","article-title":"Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomized phase 3 trial","volume":"20","author":"de Boer","year":"2019","journal-title":"Lancet Oncol"}],"container-title":["Taiwanese Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1028455924002808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1028455924002808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T15:46:11Z","timestamp":1736351171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1028455924002808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1028455924002808"],"URL":"https:\/\/doi.org\/10.1016\/j.tjog.2024.09.020","relation":{},"ISSN":["1028-4559"],"issn-type":[{"value":"1028-4559","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FIGO 2023 staging system predicts not only survival outcome but also recurrence pattern in corpus-confined endometrial cancer patients","name":"articletitle","label":"Article Title"},{"value":"Taiwanese Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjog.2024.09.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Taiwan Association of Obstetrics & Gynecology. Publishing services by Elsevier B.V\u00e9","name":"copyright","label":"Copyright"}]}}